The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum
Abstract
Acetylcholine release stimulated by nicotinic agonists was measured as radioactivity released from perfused synaptosomes prepared from mouse interpeduncular nucleus (IPN) that had been loaded with [(3)H]choline. Agonist-stimulated release was dependent upon external calcium and over 90% of released radioactivity was acetylcholine. The release process was characterized by dose response curves for 13 agonists and inhibition curves for six antagonists. alpha-Conotoxin MII did not inhibit this release, while alpha-conotoxin AuIB inhibited 50% of agonist-stimulated release. Comparison of this process with [(3)H]dopamine release from mouse striatal synaptosomes indicated that different forms of nicotinic acetylcholine receptors (nAChRs) may mediate these processes. This was confirmed by assays using mice homozygous for the beta 2 subunit null mutation. The deletion of the beta 2 subunit had no effect on agonist-stimulated acetylcholine release, but abolished agonist-stimulated release of dopamine from striatal synaptosomes. Mice heterozygous for the beta 2 subunit null mutation showed decreased dopamine release evoked by L-nicotine with no apparent change in EC(50) value, as well as similar decreases in both transient and persistent phases of release with no changes in desensitization rates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Knockout of the β2 subunit abolishes nicotine-mediated DA release (Picciotto et al. 1998;Grady et al. 2001), nicotine-induced locomotor activation (King et al. 2004), nicotine selfadministration (Picciotto et al. 1998;Maskos et al. 2005), and nicotine place preference (Walters et al. 2006;Brunzell et al. 2009;Mineur et al. 2009a).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Grady et al. 2001
In the citing paper
“Nicotinic modulation of neurotransmitter release is often subtype-specific and this specificity can vary across brain areas, with distinct nAChRs coupling to release of glutamate (α7) vs. GABA (α4β2*) (Mansvelder et al., 2002) or DA (α4/α6β2*) vs. ACh (α3β4*) (Grady et al., 2001) in the VTA, while β2* nAChRs can modulate the release of glutamate from thalamo-cortical projections (Parikh et al., 20”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Grady et al., 2001
Citations
Cites
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationThe Diversity of Neuronal Nicotinic Acetylcholine Receptors
Sargent, P. B. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.002155 · Cited by 1,052
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
Self-citationPRESYNAPTIC IONOTROPIC RECEPTORS AND THE CONTROL OF TRANSMITTER RELEASE
MacDermott, A. B., Role, L. W., & Siegelbaum, S. A. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.443 · Cited by 570
Luetje, C., & Patrick, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00837.1991 · Cited by 558
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 538
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Synapse · doi:10.1002/syn.890160105 · Cited by 521
A New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 404
Research works printed but not linked: 1
- Chavez‐Noriega L. E., 1997, Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes, J. Pharmacol. Exp. Ther., 280, 346
Cited by
Sorted by citations
Items 101–158 of 158
Kamendi, H., Stephens, C. T., Dergacheva, O., Wang, X., Huang, Z.-G., Bouairi, E., Gorini, C., McIntosh, J. M., & Mendelowitz, D. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.001 · Cited by 22
Fallon, S. M., Shearman, E., Sershen, H. W., & Lajtha, Á. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9113-z · Cited by 21
Grilli, M., Lagomarsino, F., Zappettini, S., Preda, S., Mura, E., Govoni, S. M., & Marchi, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.058 · Cited by 20
Nicotine Acts on Cholinergic Signaling Mechanisms to Directly Modulate Choroid Plexus Function
Lallai, V., Grimes, N. P., Fowler, J. P., Sequeira, P. A., Cartagena, P. M., Limón, A., Coutts, M., Monuki, E. S., Bunney, W. E., Demuro, A., et al. (2019) · eNeuro · doi:10.1523/eneuro.0051-19.2019 · Cited by 19
Gymnopilins, a product of a hallucinogenic mushroom, inhibit the nicotinic acetylcholine receptor
Kayano, T., Kitamura, N., Miyazaki, S., Ichiyanagi, T., Shimomura, N., Shibuya, I., & Aimi, T. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.01.014 · Cited by 17
Modulation of Transmitter Release Via Presynaptic Ligand-Gated Ion Channels
Schicker, K. W., Dorostkar, M. M., & Boehm, S. (2008) · Current Molecular Pharmacology · doi:10.2174/1874467210801020106 · Cited by 20
Covernton, P. J. O., & Lester, R. A. J. (2002) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00036-9 · Cited by 18
Unusual Effects of Nicotine as a Psychostimulant on Ambulatory Activity in Mice
Umezu, T. (2012) · ISRN Pharmacology · doi:10.5402/2012/170981 · Cited by 18
Jiang, J. W., Li, X., Hu, A., Zhou, G., Gao, Y.-H., Xu, C., Wu, X., & Wang, H. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1670883 · Cited by 24
Hussain, R. J., Taraschenko, O. D., & Glick, S. D. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.001 · Cited by 17
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models
Smith, L. C., & George, O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108225 · Cited by 18
[125I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors
Wu, J., Perry, D. C., Bupp, J. E., Jiang, F., Polgar, W. E., Toll, L., & Zaveri, N. T. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.023 · Cited by 16
Nicotine Addiction: Past and Present
Office on Smoking (2010) · Cited by 14
Altered acetylcholine release in the hippocampus of dystrophin-deficient mice
Parames, S. F., Coletta-Yudice, E. D., Nogueira, F. M., Nering, M. B., Hayashi, M. A. F., Lima‐Landman, M. T. R., Lapa, A. J., & Souccar, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.050 · Cited by 14
Madsen, H. B., Koghar, H. S., Pooters, T., Massalas, J. S., Drago, J., & Lawrence, A. J. (2014) · Addiction Biology · doi:10.1111/adb.12148 · Cited by 15
Dwoskin, L. P., Pivavarchyk, M., Joyce, B. M., Neugebauer, N. M., Zheng, G., Zhang, Z., Bardo, M. T., & Crooks, P. A. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_4 · Cited by 12
Breining, S. R., Bencherif, M., Grady, S. R., Whiteaker, P., Marks, M. J., Wageman, C. R., Lester, H. A., & Yohannes, D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.085 · Cited by 11
Forcelli, P. A., Turner, J. R., Lee, B. G., Olson, T. T., Xie, T., Xiao, Y., Blendy, J. A., & Kellar, K. J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.012 · Cited by 11
Recent advances in gene manipulation and nicotinic acetylcholine receptor biology
Tammimäki, A., Horton, W. J., & Stitzel, J. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.014 · Cited by 10
Dwoskin, L. P., Joyce, B. M., Zheng, G., Neugebauer, N. M., Manda, V. K., Lockman, P. R., Papke, R. L., Bardo, M. T., & Crooks, P. A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.021 · Cited by 10
Sumithran, S. P., Crooks, P. A., Xu, R., Zhu, J., Deaciuc, A. G., Wilkins, L. H., & Dwoskin, L. P. (2005) · The AAPS Journal · doi:10.1208/aapsj070119 · Cited by 9
Psicofarmacología de la nicotina y conducta adictiva
Molero‐Chamizo, A., & Muñoz-Negro, J. E. (2005) · Trastornos Adictivos · doi:10.1016/s1575-0973(05)74521-9 · Cited by 13
TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors
Wall, T. R., Henderson, B. J., Voren, G., Wageman, C. R., Deshpande, P., Cohen, B. N., Grady, S. R., Marks, M. J., Yohannes, D., Kenny, P. J., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00641 · Cited by 8
BUNGA RAMPAI INTEGRASI KEILMUAN DALAM MENGHADAPI NEW NORMAL PADA MASA PANDEMI COVID-19Preprint
Yusuf, M. R. I. (2021) · doi:10.31219/osf.io/eq4k7 · Cited by 8
Arias, H. R., Feuerbach, D., & Ortells, M. O. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.03.003 · Cited by 7
Kucinski, A. J., Wersinger, S. R., Stachowiak, E. K., Radell, M. L., Hesse, R. A., Corso, T. D., Parry, M. J., Bencherif, M., Green-Jordan, K., Letchworth, S. R., et al. (2012) · Health · doi:10.4236/health.2012.431176 · Cited by 5
Ondachi, P. W., Castro, A. H., Luetje, C. W., Wageman, C. R., Marks, M. J., Damaj, M. I., Mascarella, S. W., Navarro, H. A., & Carroll, F. I. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00107 · Cited by 5
Piri, M., Nasehi, M., Mafi, F., Shahin, M.-S., & Zarrindast, M. R. (2012) · The Journal of Qazvin University of Medical Sciences · Cited by 4
Presynaptic Nicotinic Acetylcholine Receptors and the Modulation of Circuit Excitability
Zhong, C., López‐Hernández, G. Y., Talmage, D. A., & Role, L. W. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_7 · Cited by 4
Presynaptic nicotinic acetylcholine receptors: subtypes mediating neurotransmitter release
Wonnacott, S., Mogg, A. J., Bradly, A. L., & Jones, I. W. (2001) · Cited by 4
Neurobehavioral effects of choninergic drugs in prenatal period
Владимировна, С. Е., Алексеевич, Г. Н., & Shabanov, P. D. (2017) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf1535-21 · Cited by 3
Mohan, K. R., Narayanan, M., Thangavel, R., Fenn, S. M., & Rani, J. M. (2019) · World Journal of Dentistry · doi:10.5005/jp-journals-10015-1627 · Cited by 3
Amiri, H. L., Javanbakht, M. H., Baghbanian, S. M., & Parsaeian, M. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.110845 · Cited by 2
Neurochemistry of Nicotine Dependence
Brunzell, D. H. (2007) · CRC Press eBooks · doi:10.1201/9781420054422.ch2 · Cited by 2
Smoking Effects in the Human Nervous System
Schuman‐Olivier, Z., Stoeckel, L. E., Weisz, E., & Evins, A. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00011-3 · Cited by 2
Conditional and non-conditional reward- related responses to alcohol - nicotinic mechanisms
Löf, E. (2006) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Presynaptic Nicotinic Acetylcholine Receptors: Subtypes and Functions
Marks, M. J., Grady, S. R., McClure‐Begley, T. D., O’Neill, H. C., & Zambrano, C. A. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_4 · Cited by 1
Staley, J. K., & Cosgrove, K. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch6 · Cited by 1
Nicotinic Receptors in Brain Diseases
Stitzel, J. A. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_22 · Cited by 1
Eggan, B. L., & McCallum, S. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00032-0 · Cited by 1
Marine-derived nicotinic receptor antagonist toxins: Pinnatoxins and alpha conotoxins
Hellyer, S. D. (2021) · Advances in neurotoxicology · doi:10.1016/bs.ant.2021.03.004 · Cited by 1
Presynaptic Nicotinic Acetylcholine Receptors
Wonnacott, S., Mogg, A. J., Bradly, A. L., & Jones, I. W. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.ch2 · Cited by 1
Effects of chronic nicotine on behavioural and neurochemical responses to morphine
Kivinummi, T. (2009) · Työväentutkimus Vuosikirja
Hendrickson, L. M. (2011) · PubMed · doi:10.13028/174w-zb21
Molecular mechanisms of nicotine dependence
Arias, H., & Ortells, M. O. (2016) · Journal of Pediatric Biochemistry · doi:10.1055/s-0036-1586370
Upregulation and Functionality of Neuronal Nicotinic Acetylcholine Receptors
Pakkanen, J. S. (2006) · Työväentutkimus Vuosikirja
Steiner, R. C., & Picciotto, M. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.025
de Lima Vieira Brock, P. (2019) · J. Willard Marriott Library · doi:10.26053/0j-t9x7-v964
Fox-Loe, A. M. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.461
Substance dependence and abuse
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.024
Meyer, M. D. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.63077-6
Vital Lung Capacity in Active Smokers
Sapada, E., & Asmalinda, W. (2023) · Jurnal Aisyah Jurnal Ilmu Kesehatan · doi:10.30604/jika.v8i3.2032
Ernawati, N., Ciptaningtyas, M. D., Supono, S., & Astuti, E. S. (2024) · Health Frontiers · doi:10.62255/mjhp.v2i1.127
Ionotropic Glutamate Receptor Function in Interpeduncular Nucleus Is Modulated by Nicotine Exposure
Yan, Y., Tucker, B. R., Tapp, A. E., Thomas, L. N., Drenan, D. R., & Drenan, R. M. (2025) · eNeuro · doi:10.1523/eneuro.0052-25.2025
BindingDB (2012) · UC San Diego · doi:10.7270/q2bk19xs
Buhlman, L. M. (2007) · UA Campus Repository (The University of Arizona)
Metadata
- Authors
- Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C.
- Affiliations
- University of Colorado Boulder (US)
- Yale University (US)
- Centre National de la Recherche Scientifique (FR)
- University of Utah (US)
- Corresponding author
- Collins, Allan C.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 76
- Issue
- 1
- Pages
- 258-268
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1515685619
- Cited by
- 156
- References
- 48
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 11 · 2013: 3 · 2012: 7
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH53631)
- National Institute on Drug Abuse (DA 03194, R01DA003194, R01DA012242, DA12242)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, acetylcholine release, interpeduncular nucleus, dopamine release, striatum, alpha-conotoxin MII, nicotinic agonists, calcium-dependent release, receptor desensitization, synaptosomes
- MeSH terms
- Quinolizidine Alkaloids, Acetylcholine, Alkaloids, Animals, Azocines, Calcium, Choline, Corpus Striatum, Dopamine, Dose-Response Relationship, Drug, Female, Heterozygote, Homozygote, Male, Mesencephalon, Mice, Inbred C57BL, Mice, Mutant Strains, Quinolizines, Receptors, Nicotinic, Synaptosomes, Presynaptic Terminals, Nicotinic Agonists, Nicotinic Antagonists, Conotoxins, Protein Subunits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
